Akso Health Group current report, Q4 FY2018

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of December 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on December 10, 2018. The filing serves to distribute a press release (Exhibit 99.1) but does not contain the full text of that release within the provided content.

Key Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover sheet for an external press release rather than a financial statement.

Material Changes

The filing text does not provide information regarding material changes versus prior comparable periods. No comparative financial data is included in the source text.

Guidance, Outlook, and Risks

The filing text does not include management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These details are presumably contained in the referenced Exhibit 99.1 (Press Release), which is not included in the input content.

Investor Verification Checklist

  • Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial results or corporate announcements intended for this filing.
  • Confirm the discrepancy between the requested company name ("Akso Health Group") and the registrant name in the filing ("Hexindai Inc.").
  • Review the full press release for any material risk factors or forward-looking statements not captured in this summary.